INCYTE CORP — Director's Dealing 2025

Jan 22, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2025-01-17

Reporting Person: Stein Steven H (EVP & Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-01-21	Common Stock	S	12352	$72.69	Disposed	66967	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-17	Employee Stock Option (right to buy)	$71.93	A	28202	Acquired	2035-01-16	Common Stock (28202)	Direct

Footnotes

F1: This includes an aggregate of 64,408 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.

F2: Beginning January 17, 2025, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2025 and the remainder vesting monthly over three years.